US Stock MarketDetailed Quotes

MRKR Marker Therapeutics

Watchlist

2.8000
+0.1466+5.52%

Close Oct 4 16:00 ET

24.98MMarket Cap-2393P/E (TTM)

Marker Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-44.17%2.31M

-40.85%2.55M

-26.32%14.58M

-3.32%2.94M

-45.08%3.2M

-21.53%4.13M

-56.00%4.31M

-49.87%19.79M

-68.88%3.04M

-41.87%5.83M

Selling and administrative expenses

-54.66%1.14M

-43.80%1.22M

-34.05%7.48M

-14.76%1.38M

-56.32%1.41M

-19.66%2.52M

-41.94%2.17M

-12.29%11.34M

-45.94%1.62M

-0.15%3.23M

-General and administrative expense

-54.66%1.14M

-43.80%1.22M

-34.05%7.48M

-14.76%1.38M

-56.32%1.41M

-19.66%2.52M

-41.94%2.17M

-12.29%11.34M

-45.94%1.62M

-0.15%3.23M

Research and development costs

-1.79%2.34M

-23.74%2.58M

-12.96%10.42M

19.93%2.62M

-43.07%2.04M

-18.67%2.38M

-51.94%3.38M

-56.94%11.97M

-72.78%2.18M

-47.06%3.59M

Other operating expenses

-53.31%-1.17M

-0.79%-1.24M

5.76%-3.31M

-39.17%-1.06M

74.23%-257.61K

3.52%-762.66K

-28.00%-1.23M

-182.96%-3.51M

---759.14K

---999.57K

Operating profit

44.17%-2.31M

40.85%-2.55M

26.32%-14.58M

3.32%-2.94M

45.08%-3.2M

21.53%-4.13M

56.00%-4.31M

49.87%-19.79M

68.88%-3.04M

41.87%-5.83M

Net non-operating interest income expense

228.93%115.39K

84.51%156.2K

117.35%539.16K

84.02%201.34K

118.63%218.09K

-1.97%35.08K

2,615.88%84.65K

4,251.98%248.06K

11,191.02%109.41K

12,510.62%99.75K

Non-operating interest income

228.93%115.39K

84.51%156.2K

117.35%539.16K

84.02%201.34K

118.63%218.09K

-1.97%35.08K

2,615.88%84.65K

4,251.98%248.06K

11,191.02%109.41K

12,510.62%99.75K

Other net income (expense)

90.32%-232.97K

-114.09K

Other non- operating income (expenses)

----

90.32%-232.97K

---114.09K

----

Income before tax

46.51%-2.19M

43.36%-2.39M

28.99%-14.04M

10.08%-2.74M

47.93%-2.98M

21.67%-4.1M

57.37%-4.22M

52.78%-19.78M

68.83%-3.04M

53.93%-5.73M

Income tax

3.68K

Net income

-187.16%-2.19M

51.83%-2.39M

72.48%-8.24M

27.31%-2.8M

56.91%-2.98M

127.21%2.52M

49.88%-4.97M

28.53%-29.93M

60.50%-3.86M

44.33%-6.92M

Net income continuous Operations

46.51%-2.19M

43.36%-2.39M

28.97%-14.05M

9.96%-2.74M

47.93%-2.98M

21.67%-4.1M

57.37%-4.22M

52.78%-19.78M

68.83%-3.04M

53.93%-5.73M

Net income discontinuous operations

--0

157.21%5.81M

92.26%-62.94K

--0

264.90%6.61M

---742.75K

---10.15M

---813.06K

---1.19M

Minority interest income

Net income attributable to the parent company

-187.16%-2.19M

51.83%-2.39M

72.48%-8.24M

27.31%-2.8M

56.91%-2.98M

127.21%2.52M

49.88%-4.97M

28.53%-29.93M

60.50%-3.86M

44.33%-6.92M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-187.16%-2.19M

51.83%-2.39M

72.48%-8.24M

27.31%-2.8M

56.91%-2.98M

127.21%2.52M

49.88%-4.97M

28.53%-29.93M

60.50%-3.86M

44.33%-6.92M

Basic earnings per share

-186.21%-0.25

52.63%-0.27

73.74%-0.94

28.89%-0.32

59.04%-0.34

126.13%0.29

52.10%-0.57

34.55%-3.58

61.54%-0.45

44.67%-0.83

Diluted earnings per share

-186.21%-0.25

52.63%-0.27

73.74%-0.94

28.89%-0.32

59.04%-0.34

126.13%0.29

52.10%-0.57

34.55%-3.58

61.54%-0.45

44.67%-0.83

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-44.17%2.31M	-40.85%2.55M	-26.32%14.58M	-3.32%2.94M	-45.08%3.2M	-21.53%4.13M	-56.00%4.31M	-49.87%19.79M	-68.88%3.04M	-41.87%5.83M
Selling and administrative expenses	-54.66%1.14M	-43.80%1.22M	-34.05%7.48M	-14.76%1.38M	-56.32%1.41M	-19.66%2.52M	-41.94%2.17M	-12.29%11.34M	-45.94%1.62M	-0.15%3.23M
-General and administrative expense	-54.66%1.14M	-43.80%1.22M	-34.05%7.48M	-14.76%1.38M	-56.32%1.41M	-19.66%2.52M	-41.94%2.17M	-12.29%11.34M	-45.94%1.62M	-0.15%3.23M
Research and development costs	-1.79%2.34M	-23.74%2.58M	-12.96%10.42M	19.93%2.62M	-43.07%2.04M	-18.67%2.38M	-51.94%3.38M	-56.94%11.97M	-72.78%2.18M	-47.06%3.59M
Other operating expenses	-53.31%-1.17M	-0.79%-1.24M	5.76%-3.31M	-39.17%-1.06M	74.23%-257.61K	3.52%-762.66K	-28.00%-1.23M	-182.96%-3.51M	---759.14K	---999.57K
Operating profit	44.17%-2.31M	40.85%-2.55M	26.32%-14.58M	3.32%-2.94M	45.08%-3.2M	21.53%-4.13M	56.00%-4.31M	49.87%-19.79M	68.88%-3.04M	41.87%-5.83M
Net non-operating interest income expense	228.93%115.39K	84.51%156.2K	117.35%539.16K	84.02%201.34K	118.63%218.09K	-1.97%35.08K	2,615.88%84.65K	4,251.98%248.06K	11,191.02%109.41K	12,510.62%99.75K
Non-operating interest income	228.93%115.39K	84.51%156.2K	117.35%539.16K	84.02%201.34K	118.63%218.09K	-1.97%35.08K	2,615.88%84.65K	4,251.98%248.06K	11,191.02%109.41K	12,510.62%99.75K
Other net income (expense)								90.32%-232.97K	-114.09K
Other non- operating income (expenses)	----	----	----	----	----	----	----	90.32%-232.97K	---114.09K	----
Income before tax	46.51%-2.19M	43.36%-2.39M	28.99%-14.04M	10.08%-2.74M	47.93%-2.98M	21.67%-4.1M	57.37%-4.22M	52.78%-19.78M	68.83%-3.04M	53.93%-5.73M
Income tax			3.68K					0
Net income	-187.16%-2.19M	51.83%-2.39M	72.48%-8.24M	27.31%-2.8M	56.91%-2.98M	127.21%2.52M	49.88%-4.97M	28.53%-29.93M	60.50%-3.86M	44.33%-6.92M
Net income continuous Operations	46.51%-2.19M	43.36%-2.39M	28.97%-14.05M	9.96%-2.74M	47.93%-2.98M	21.67%-4.1M	57.37%-4.22M	52.78%-19.78M	68.83%-3.04M	53.93%-5.73M
Net income discontinuous operations	--0	--0	157.21%5.81M	92.26%-62.94K	--0	264.90%6.61M	---742.75K	---10.15M	---813.06K	---1.19M
Minority interest income
Net income attributable to the parent company	-187.16%-2.19M	51.83%-2.39M	72.48%-8.24M	27.31%-2.8M	56.91%-2.98M	127.21%2.52M	49.88%-4.97M	28.53%-29.93M	60.50%-3.86M	44.33%-6.92M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-187.16%-2.19M	51.83%-2.39M	72.48%-8.24M	27.31%-2.8M	56.91%-2.98M	127.21%2.52M	49.88%-4.97M	28.53%-29.93M	60.50%-3.86M	44.33%-6.92M
Basic earnings per share	-186.21%-0.25	52.63%-0.27	73.74%-0.94	28.89%-0.32	59.04%-0.34	126.13%0.29	52.10%-0.57	34.55%-3.58	61.54%-0.45	44.67%-0.83
Diluted earnings per share	-186.21%-0.25	52.63%-0.27	73.74%-0.94	28.89%-0.32	59.04%-0.34	126.13%0.29	52.10%-0.57	34.55%-3.58	61.54%-0.45	44.67%-0.83
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data